Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prestige Consumer Healthcare (PBH) Change in Cash (2016 - 2025)

Prestige Consumer Healthcare has reported Change in Cash over the past 16 years, most recently at -$56.7 million for Q4 2025.

  • Quarterly results put Change in Cash at -$56.7 million for Q4 2025, down 8418.47% from a year ago — trailing twelve months through Dec 2025 was $11.5 million (up 190.25% YoY), and the annual figure for FY2025 was $51.4 million, up 527.75%.
  • Change in Cash for Q4 2025 was -$56.7 million at Prestige Consumer Healthcare, down from -$20.4 million in the prior quarter.
  • Over the last five years, Change in Cash for PBH hit a ceiling of $131.3 million in Q2 2021 and a floor of -$120.8 million in Q3 2021.
  • Median Change in Cash over the past 5 years was $1.4 million (2023), compared with a mean of $13500.0.
  • Biggest five-year swings in Change in Cash: soared 456.67% in 2021 and later plummeted 8418.47% in 2025.
  • Prestige Consumer Healthcare's Change in Cash stood at -$21.8 million in 2021, then skyrocketed by 301.45% to $43.9 million in 2022, then tumbled by 91.92% to $3.5 million in 2023, then tumbled by 118.77% to -$666000.0 in 2024, then plummeted by 8418.47% to -$56.7 million in 2025.
  • The last three reported values for Change in Cash were -$56.7 million (Q4 2025), -$20.4 million (Q3 2025), and $41.6 million (Q2 2025) per Business Quant data.